Thuss-Patience P - Search Results

1

Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data.

Janowitz T, Thuss-Patience P, Marshall A, Kang JH, Connell C, Cook N, Dunn J, Park SH, Ford H. Janowitz T, et al. Br J Cancer. 2016 Feb 16;114(4):381-7. doi: 10.1038/bjc.2015.452. Br J Cancer. 2016. PMID: 26882063 Free PMC article.

2

Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.

Thuss-Patience PC, Kretzschmar A, Krenn V, Dörken B, Reichardt P. Thuss-Patience PC, et al. Onkologie. 2003 Feb;26(1):63-5. doi: 10.1159/000069866. Onkologie. 2003. PMID: 12624520 Clinical Trial.

3

Chemotherapy in alveolar soft part sarcomas. What do we know?

Reichardt P, Lindner T, Pink D, Thuss-Patience PC, Kretzschmar A, Dörken B. Reichardt P, et al. Eur J Cancer. 2003 Jul;39(11):1511-6. doi: 10.1016/s0959-8049(03)00264-8. Eur J Cancer. 2003. PMID: 12855256 Review.

4

Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial.

Köhne CH, Catane R, Klein B, Ducreux M, Thuss-Patience P, Niederle N, Gips M, Preusser P, Knuth A, Clemens M, Bugat R, Figer I, Shani A, Fages B, Di Betta D, Jacques C, Wilke HJ. Köhne CH, et al. Br J Cancer. 2003 Sep 15;89(6):997-1001. doi: 10.1038/sj.bjc.6601226. Br J Cancer. 2003. PMID: 12966415 Free PMC article. Clinical Trial.

5

Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.

Thuss-Patience PC, Kretzschmar A, Repp M, Kingreen D, Hennesser D, Micheel S, Pink D, Scholz C, Dörken B, Reichardt P. Thuss-Patience PC, et al. J Clin Oncol. 2005 Jan 20;23(3):494-501. doi: 10.1200/JCO.2005.02.163. J Clin Oncol. 2005. PMID: 15659494 Clinical Trial.

6

Docetaxel in the treatment of gastric cancer.

Thuss-Patience PC, Kretzschmar A, Reichardt P. Thuss-Patience PC, et al. Future Oncol. 2006 Oct;2(5):603-20. doi: 10.2217/14796694.2.5.603. Future Oncol. 2006. PMID: 17026452 Review.

7

[Clinical and pathological prognostic factors for cancers of the esophagogastric junction].

Schmidt SC, Schlechtweg N, Veltzke-Schlieker W, Thuss-Patience P, Pratschke J, Neuhaus P, Schumacher G. Schmidt SC, et al. Zentralbl Chir. 2009 Sep;134(5):455-61. doi: 10.1055/s-0029-1224512. Epub 2009 Sep 15. Zentralbl Chir. 2009. PMID: 19757346 German.

8

[Metastatic gastric cancer: does second-line chemotherapy make sense?].

Breithaupt K, Thuss-Patience PC. Breithaupt K, et al. Dtsch Med Wochenschr. 2010 Sep;135(38):1872-6. doi: 10.1055/s-0030-1263331. Epub 2010 Sep 14. Dtsch Med Wochenschr. 2010. PMID: 20842609 Review. German. No abstract available.

9

Hepatic arterial infusion chemotherapy for liver metastases from gastric cancer: an analysis in Western patients.

Flörcken A, Schaefer C, Bichev D, Breithaupt K, Dogan Y, Schumacher G, Gebauer B, Riess H, Dörken B, Thuss-Patience PC. Flörcken A, et al. Tumori. 2011 Jan-Feb;97(1):19-24. doi: 10.1177/030089161109700104. Tumori. 2011. PMID: 21528658

10

Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Thuss-Patience PC, Kretzschmar A, Bichev D, Deist T, Hinke A, Breithaupt K, Dogan Y, Gebauer B, Schumacher G, Reichardt P. Thuss-Patience PC, et al. Eur J Cancer. 2011 Oct;47(15):2306-14. doi: 10.1016/j.ejca.2011.06.002. Eur J Cancer. 2011. PMID: 21742485 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters